Login / Signup

Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility.

Ji-Hyun KangJi-Eun LeeSo-Jeong JeongChun-Woong ParkDong-Wook KimKwon-Yeon Weon
Published in: Drug design, development and therapy (2022)
The results imply that high-dose RIV can be administered regardless of the meal, reducing the risk of changing the drug effect due to the patient's administration mistake.
Keyphrases
  • high dose
  • low dose
  • venous thromboembolism
  • atrial fibrillation
  • case report
  • drug delivery
  • stem cell transplantation
  • pulmonary embolism
  • emergency department
  • capillary electrophoresis
  • electronic health record